A method of decision analysis quantifying the effects of age and comorbidities on the probability of deriving significant benefit from medical treatments

摘要

BackgroundThe external validity, or generalizability, of trials and guidelines has been considered poor in the context of multiple morbidity. How multiple morbidity might affect the magnitude of benefit of a given treatment, and thereby external validity, has had little study.